Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 28 09 2018
accepted: 12 01 2019
pubmed: 9 5 2019
medline: 21 10 2020
entrez: 9 5 2019
Statut: ppublish

Résumé

Primary intratumoral hemorrhage as a presenting sign is rare in children with medulloblastomas but may result in severe complications. Given the distinct properties of molecular medulloblastoma subgroups, the impact on neurosurgical practice has still to be defined. To investigate both clinical and radiological presentation of intratumoral hemorrhage in medulloblastoma patients in the context of molecular subgroups. Data of all consecutive medulloblastoma patients treated at our institution between 1993 and 2018 (n = 104) were retrospectively reviewed in respect of clinical and radiological presentation as well as molecular subgroups. For cases with available tumor tissue (n = 86), subgroups were assigned by either 450 K methylation array or immunohistochemistry and CTNNB1 sequencing. Available imaging at diagnosis (n = 62) was reviewed by an experienced neuroradiologist. Within the entire cohort, 4 patients (4%) presented with massive spontaneous hemorrhage. Although no patient died as a direct consequence of hemorrhage, all suffered from serious sequelae. Moreover, 3 additional patients displayed radiological evidence of significant hemorrhage. Interestingly, all 7 cases belonged to the wingless (WNT) subgroup (n = 13), resulting in intratumoral hemorrhage in 54% (7/13) of pediatric WNT medulloblastomas. In contrast, significant hemorrhage was absent in all other molecular subgroups. Our results suggest that a substantial proportion of pediatric WNT medulloblastomas display significant intratumoral hemorrhage at the time of diagnosis. Consequently, the presence of significant hemorrhage in fourth ventricle childhood tumors is suggestive of WNT medulloblastoma and should lead to a less aggressive attempt for total resection in this prognostically favorable tumor type.

Sections du résumé

BACKGROUND
Primary intratumoral hemorrhage as a presenting sign is rare in children with medulloblastomas but may result in severe complications. Given the distinct properties of molecular medulloblastoma subgroups, the impact on neurosurgical practice has still to be defined.
OBJECTIVE
To investigate both clinical and radiological presentation of intratumoral hemorrhage in medulloblastoma patients in the context of molecular subgroups.
METHODS
Data of all consecutive medulloblastoma patients treated at our institution between 1993 and 2018 (n = 104) were retrospectively reviewed in respect of clinical and radiological presentation as well as molecular subgroups. For cases with available tumor tissue (n = 86), subgroups were assigned by either 450 K methylation array or immunohistochemistry and CTNNB1 sequencing. Available imaging at diagnosis (n = 62) was reviewed by an experienced neuroradiologist.
RESULTS
Within the entire cohort, 4 patients (4%) presented with massive spontaneous hemorrhage. Although no patient died as a direct consequence of hemorrhage, all suffered from serious sequelae. Moreover, 3 additional patients displayed radiological evidence of significant hemorrhage. Interestingly, all 7 cases belonged to the wingless (WNT) subgroup (n = 13), resulting in intratumoral hemorrhage in 54% (7/13) of pediatric WNT medulloblastomas. In contrast, significant hemorrhage was absent in all other molecular subgroups.
CONCLUSION
Our results suggest that a substantial proportion of pediatric WNT medulloblastomas display significant intratumoral hemorrhage at the time of diagnosis. Consequently, the presence of significant hemorrhage in fourth ventricle childhood tumors is suggestive of WNT medulloblastoma and should lead to a less aggressive attempt for total resection in this prognostically favorable tumor type.

Identifiants

pubmed: 31065705
pii: 5486579
doi: 10.1093/neuros/nyz148
doi:

Substances chimiques

Wnt Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

478-484

Informations de copyright

© Congress of Neurological Surgeons 2019.

Auteurs

Dominik Reisinger (D)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Johannes Gojo (J)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Gregor Kasprian (G)

Department of Radiology, Medical University of Vienna, Vienna, Austria.

Christine Haberler (C)

Institute of Neurology, Medical University of Vienna, Vienna, Austria.

Andreas Peyrl (A)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Amedeo A Azizi (AA)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Lisa Mayr (L)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Monika Chocholous (M)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Marcel Kool (M)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neuro-Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany.
German Cancer Consortium DKTK, Heidelberg, Germany.

Thomas Czech (T)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Irene Slavc (I)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH